rs201866563
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_001077415.3(CRELD1):c.575G>A(p.Cys192Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000323 in 1,614,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001077415.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRELD1 | NM_001077415.3 | c.575G>A | p.Cys192Tyr | missense_variant | 6/11 | ENST00000452070.6 | NP_001070883.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRELD1 | ENST00000452070.6 | c.575G>A | p.Cys192Tyr | missense_variant | 6/11 | 2 | NM_001077415.3 | ENSP00000393643.2 | ||
ENSG00000288550 | ENST00000683484.1 | n.*223G>A | non_coding_transcript_exon_variant | 19/24 | ENSP00000507040.1 | |||||
ENSG00000288550 | ENST00000683484.1 | n.*223G>A | 3_prime_UTR_variant | 19/24 | ENSP00000507040.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152178Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000195 AC: 49AN: 251352Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135880
GnomAD4 exome AF: 0.000344 AC: 503AN: 1461880Hom.: 0 Cov.: 33 AF XY: 0.000341 AC XY: 248AN XY: 727240
GnomAD4 genome AF: 0.000125 AC: 19AN: 152178Hom.: 0 Cov.: 31 AF XY: 0.000161 AC XY: 12AN XY: 74350
ClinVar
Submissions by phenotype
Jeffries-Lakhani neurodevelopmental syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Heidelberg University | May 24, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 29, 2024 | - - |
not provided Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | CRELD1: PP3 - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 05, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32437232, 37947183) - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 04, 2024 | The c.575G>A (p.C192Y) alteration is located in coding exon 5 of the CRELD1 gene. This alteration results from a G to A substitution at nucleotide position 575, causing the cysteine (C) at amino acid position 192 to be replaced by a tyrosine (Y). Based on data from gnomAD, the A allele has an overall frequency of 0.018% (52/282700) total alleles studied. The highest observed frequency was 0.037% (48/129056) of European (non-Finnish) alleles. This variant has been reported as a homozygous finding in a female with epileptic encephalopathy (de Kovel, 2016). In a cohort of individuals with biallelic variants in CRELD1 presenting with early-onset neurodevelopmental disorder features and slowly progressive non-neurologic features, this was detected in compound heterozygous form in nine probands and as a homozygous finding in one other proband (Jeffries, 2023). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. - |
Atrioventricular septal defect, susceptibility to, 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 06, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 238218). This variant has not been reported in the literature in individuals affected with CRELD1-related conditions. This variant is present in population databases (rs201866563, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 192 of the CRELD1 protein (p.Cys192Tyr). - |
CRELD1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Undiagnosed Diseases Network, NIH | Feb 04, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at